ArticleGeoHealth2026
Changes of Long-Term Exposure to Ultrafine Particles From 2010 to 2019 in High Income Countries in Relation to Cardiovascular Diseases.
Article in GeoHealth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ultrafine particles (UFPs) are ubiquitous in the atmosphere and occur at high number concentrations. Despite their ability to penetrate deep into the respiratory system, their harmfulness remains insufficiently studied, primarily due to the lack of reliable standardised and harmonized long-term global exposure data. In this study, we applied an ecological approach to provide an exploratory assessment of the long-term exposure to UFPs from 2010 to 2019 in high-income countries (HICs) in relation to cardiovascular disease (CVD) risk using publicly available country-level aggregate data. To minimize social and demographic confounding factors and use reliable UFP estimation, we focus exclusively on HICs and the findings should not be generalized globally. Using a newly developed global UFP data set, we estimated population-weighted exposure (PWE) over the past decade. These estimates were combined with CVD aggregate data to identify statistically significant co-occurrences between PWE of UFPs and three health outcomes: disability-adjusted life years (DALYs), years of life lost (YLLs), and years of life lived with disability (YLDs). The findings suggest consistent patterns between long-term exposures to UFPs and CVDs. Aligning with the current literature, we suggest that further research into possible effects on CVDs due to long-term UFPs exposure is needed. Coherent with the last EU directives, our findings highlight the relevance of monitoring UFPs as a public health priority even when
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.